Status:

RECRUITING

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Lead Sponsor:

Eli Lilly and Company

Conditions:

Obesity

Overweight

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight ma...

Eligibility Criteria

Inclusion

  • Have a body mass index (BMI)
  • ≥30 kilogram/square meter (kg/m²), or
  • ≥27 kg/m² and \<30 kg/m², or with at least 1 weight-related comorbidity
  • Have had a stable body weight for the 3 months prior to randomization (\<5%) body weight gain and/or loss.

Exclusion

  • Have a prior or planned surgical treatment for obesity, except prior liposuction or abdominoplasty, if performed \>1 year prior to screening.
  • Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history of ketoacidosis or hyperosmolar coma.
  • Have poorly controlled hypertension.
  • Have signs and symptoms of any liver disease other than nonalcoholic fatty liver disease.
  • Have any of the following cardiovascular conditions within 3 months prior to screening:
  • acute myocardial infarction
  • cerebrovascular accident (stroke)
  • unstable angina, or
  • hospitalization due to congestive heart failure.
  • Have a history of symptomatic gallbladder disease within the past 2 years.
  • Have a lifetime history of suicide attempts.

Key Trial Info

Start Date :

November 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

1217 Patients enrolled

Trial Details

Trial ID

NCT06143956

Start Date

November 17 2023

End Date

September 1 2026

Last Update

December 23 2025

Active Locations (54)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (54 locations)

1

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

Chandler, Arizona, United States, 85225

2

HOPE Research Institute

Phoenix, Arizona, United States, 85032

3

Headlands Research - Scottsdale

Scottsdale, Arizona, United States, 85260

4

The Institute for Liver Health II dba Arizona Liver Health-Tucson

Tucson, Arizona, United States, 85712